Mr. Trevor Vieweg reports

MEDBRIGHT AI ANNOUNCES REJUVENATION MEDICAL GROUP, A LARGE CANADIAN CLINIC GROUP, AS FIRST INTERNATIONAL CUSTOMER FOR MEDMATRIX, THE AI-DRIVEN DATA AND ANALYTICS PLATFORM

Rejuvenation medical group, a prominent dermatology group and a leader in advanced dermatological care, has decided to adopted Medbright AI Investments Inc.'s MedMatrix across all its clinics in Canada. Renowned for its cutting-edge dermatology treatments and facilities, Rejuvenation medical group caters to over 750,000 patients each year. Its extensive network includes nine clinics spread across three provinces in Canada. The group boasts a highly skilled team comprising 21 dermatologists, five Mohs surgeons, two plastic surgeons and 13 general practitioners specializing in dermatology. This strategic implementation of MedMatrix is set to enhance its already formidable health care offerings.

For over 40 years, Rejuvenation medical group has established a reputation for excellence in providing comprehensive medical, surgical, cosmetic and laser treatments. Under the guidance of esteemed dermatologists, the group is dedicated to delivering world-class services, ensuring every patient benefits from the highest standard of care.

Medbright AI is a significant shareholder in MedMatrix, an artificial-intelligence-powered data analytics platform. MedMatrix harnesses the power of artificial intelligence to evaluate and analyze key aspects of health care facilities, including patient needs and resource matching, revenue cycle management, patient demographics, facility geography, and competition. Through its advanced AI and data analytics capabilities, MedMatrix works alongside health care professionals to optimize each of these critical areas, resulting in more efficient clinic operations and improved patient outcomes.

"In an operation as large and complex as ours, there is a clear need for AI to help improve the patient experience and clinic revenue," said Dr. Paul Kuzel, MD, medical director and dermatologist at Rejuvenation medical group. "We are excited to work with MedMatrix to improve our clinic operations across several areas in operations and research."

"Bringing Rejuvenation medical group and the entire team of highly talented medical professionals across their clinics as customers of the MedMatrix platform is a major win for both sides," said Trevor Vieweg, chief executive officer of Medbright. "The scale of Rejuvenation's operations make it a perfect opportunity to show the value of MedMatrix. We look forward to demonstrating the benefits of MedMatrix in clinic operations at Rejuvenation."

About Medbright AI Investments Inc.

Medbright AI is a capital allocator focused on investing in health care technology companies. The team at Medbright prides itself on unparalleled access to opportunities, as well as structuring unique and advantageous investments. Medbright's mission is to construct a portfolio of synergistic investments to generate superior returns for shareholders. Medbright will focus on significant near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance.

We seek Safe Harbor.